Biotest AG, Dreieich/Germany, is a global pharmaceutical, diagnostics and biotherapeutics company specializing in innovative haematology and immunology products. The division pharmacy develops pharmaceutical products on basis of human blood plasma like immunglobulins, coagulating factors and albumins which are used on disorders of the immune system or the haematinic systems.
Furthermore, one of Biotest’ highest priority research projects is the development of monoclonal antibodies, which will open up new prospects in the treatment of rheumatism, leukaemia and other autoimmune diseases. The division diagnostics covers reagents and systems of the serology and microbiology, which are used for example with blood transfusions. Biotest employs worldwide approx. 1,1000 employees. The stocks of Biotest AG are listed in the Prime Standard.
Biotest AG, Dreieich/Germany, is a global pharmaceutical, diagnostics and biotherapeutics company specializing in innovative haematology and immunolgy products. The division pharmacy develops pharmaceutical products on basis of human blood plasma like immunglobulins,
Biotest
<< Back